Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.

Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.

Item
http://www.wikidata.org/entity/Q30712257
Imaging neuroinflammation in multiple sclerosis using TSPO-PETPrimary progressive multiple sclerosis: current therapeutic strategies and future perspectivesTherapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy.Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative DiseasesTerahertz Spectroscopic Diagnosis of Myelin Deficit Brain in Mice and Rhesus Monkey with Chemometric Techniques.CSF isoprostane levels are a biomarker of oxidative stress in multiple sclerosis.Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureMtDNA T4216C variation in multiple sclerosis: a systematic review and meta-analysis.Randomized trial of erhuangfang for relapsing multiple sclerosis.The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis.Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.Grey matter atrophy is associated with disability increase in natalizumab-treated patients.The Efficacy of Psychological Interventions for Managing Fatigue in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs.Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
P2860

Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.

Item
http://www.wikidata.org/entity/Q30712257
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.
@ast
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.
@en
type
label
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.
@ast
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.
@en
prefLabel
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.
@ast
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932